E-mail a Wiley Online Library Link

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Karla V. Ballman, Mika Leinonen, Ronald P. DeMatteo and Peter Reichardt Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib Cancer 120

Version of Record online: 15 APR 2014 | DOI: 10.1002/cncr.28669

The most important factors that predict for gastrointestinal stromal tumor recurrence in a patient population treated with surgery and adjuvant imatinib are tumor mitotic count and site in the gastrointestinal tract. The 2 predictive scores developed effectively stratified the risk.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field